Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 10 Mar 2025

Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Hongyu Pan
Minghao Ruan
Riming Jin
Jin Zhang
Yao Li
Dong Wu
Lijie Zhang
Wen Sun
Ruoyu Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1385304

1,379 views
1 citation

Case Report

Published on 06 Mar 2025

Tislelizumab-induced type 1 diabetic ketoacidosis in a patient with small cell lung cancer: a case report

in Cancer Immunity and Immunotherapy

Jie Zhu
Wen-jie Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1498701

1,478 views
1 citation

Original Research

Published on 05 Mar 2025

Integrated single-cell analysis reveals the regulatory network of disulfidptosis-related lncRNAs in bladder cancer: constructing a prognostic model and predicting treatment response

in Cancer Immunity and Immunotherapy

Jiafu Xiao
Wuhao Liu
Jianxin Gong
Weifeng Lai
Neng Luo
Yingfan He
Junrong Zou
Zhihua He

Frontiers in Oncology

doi 10.3389/fonc.2025.1527036

1,924 views

Review

Published on 04 Mar 2025

Research and progress of microRNA-136 in metastatic tumors

in Cancer Immunity and Immunotherapy

Chenwen Wang
Zixiong Chen
Wei Ni
Jiang Wang
Wei Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1555270

2,893 views

Editorial

Published on 28 Feb 2025

Editorial: Circadian rhythms and cancer hallmarks: toward advances in immune-based therapeutics, and outcomes

in Cancer Immunity and Immunotherapy

Elizabeth Cash
Pasquale F. Innominato
Sandra E. Sephton

Frontiers in Oncology

doi 10.3389/fonc.2025.1571086

780 views

Systematic Review

Published on 27 Feb 2025

Bibliometric analysis: a study of the microenvironment in cervical cancer (2000-2024)

in Cancer Immunity and Immunotherapy

Yun-Tao Zhang
Yan-Ni Wei
Chen-Chen Liu
Mai-Qing Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1508173

1,660 views
1 citation

Review

Published on 24 Feb 2025

Advances in targeting protein S-palmitoylation in tumor immunity and therapy

in Cancer Immunity and Immunotherapy

Miaomiao Han
Yuanhao Lv
Yiyang Chen
Zhaoyi Li
Jiaqi Tian
Hongyan Zhou
Yunlong Wang
Wei Su
Jiateng Zhong

Frontiers in Oncology

doi 10.3389/fonc.2025.1547636

2,583 views
2 citations

Systematic Review

Published on 24 Feb 2025

Association between human leukocyte antigen E expression and outcomes in solid tumors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Javier David Benitez Fuentes
Jorge Bartolome Arcilla
Antonio David Lazaro Sanchez
Alicia de Luna Aguilar
Kauzar Mohamed Mohamed
Kissy Guevara-Hoyer
Pablo Ballestin Martinez
Miguel Borregon Rivilla
Asia Ferrandez Arias
Silvia Sánchez-Ramon

Frontiers in Oncology

doi 10.3389/fonc.2025.1525924

2,196 views

Original Research

Published on 21 Feb 2025

Prognostic significance of the inhibitory-to-stimulatory immune checkpoint ratio in patients with breast cancer

in Cancer Immunity and Immunotherapy

Chuangang Tang
Xiang Hu
Dawei Hao
Tao Chen
Pei Wang
Changwen Li
Chengling Chen
Yongcheng Li
Xiaowen Hao
Zeng Yuan

Frontiers in Oncology

doi 10.3389/fonc.2025.1524861

897 views

Systematic Review

Published on 14 Feb 2025

Global research prospects and trends in TFH cells and tumors: a bibliometric analysis

in Cancer Immunity and Immunotherapy

Hao Lei
Jin Hu
Junpeng Zhu
Runze Li
Yu Zhao
Yaqi Zhao
Guisheng He
Tao Song
Chong Lu
Wuping Zheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1443890

1,983 views

Review

Published on 14 Feb 2025

Are all programmed cell death protein 1 inhibitors the same?

in Cancer Immunity and Immunotherapy

Jochen H. Lorch
Stacey Stein
Martin J. Edelman

Frontiers in Oncology

doi 10.3389/fonc.2025.1535030

2,089 views

Case Report

Published on 12 Feb 2025

Case report: Low-dose radiation reverses pembrolizumab resistance in melanoma

in Cancer Immunity and Immunotherapy

Ka Hey Agnes Fong
Isaac Ho
Tsz Him So

Frontiers in Oncology

doi 10.3389/fonc.2025.1483117

1,306 views

Case Report

Published on 07 Feb 2025

Dramatic response of advanced pulmonary sarcomatoid carcinoma to tislelizumab combined with anlotinib: a case report

in Cancer Immunity and Immunotherapy

Ranran Li
Xiliang Di
Yuan Li
Hao Li
Chonghua Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1531700

1,403 views

Original Research

Published on 07 Feb 2025

Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer

in Cancer Immunity and Immunotherapy

Yuanyuan Wang
Chenxi Hu
Tianpeng Du
Jiawen Li
Kaiyuan Hui
Xiaodong Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1528004

1,135 views

Editorial

Published on 07 Feb 2025

Editorial: Deciphering the regulatory role of transcription factors in cancer immune infiltration

in Cancer Immunity and Immunotherapy

Qian Yang
Jinfen Xiao
Yujia Lan

Frontiers in Oncology

doi 10.3389/fonc.2025.1563949

692 views

Review

Published on 07 Feb 2025

Advances in preclinical and clinical studies of oncolytic virus combination therapy

in Cancer Immunity and Immunotherapy

Wenlong Du
Jintong Na
Liping Zhong
Pumin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1545542

4,158 views
1 citation